• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用饱和基因组编辑降低基因检测中的不确定性。

Reducing uncertainty in genetic testing with Saturation Genome Editing.

作者信息

Dace Phoebe, Findlay Gregory M

机构信息

The Genome Function Laboratory, The Francis Crick Institute, 1 Midland Rd, London, United Kingdom.

出版信息

Med Genet. 2022 Nov 29;34(4):297-304. doi: 10.1515/medgen-2022-2159. eCollection 2022 Dec.

DOI:10.1515/medgen-2022-2159
PMID:38836089
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11006300/
Abstract

Accurate interpretation of human genetic data is critical for optimizing outcomes in the era of genomic medicine. Powerful methods for testing genetic variants for functional effects are allowing researchers to characterize thousands of variants across disease genes. Here, we review experimental tools enabling highly scalable assays of variants, focusing specifically on Saturation Genome Editing (SGE). We discuss examples of how this technique is being implemented for variant testing at scale and describe how SGE data for have been clinically validated and used to aid variant interpretation. The initial success at predicting variant pathogenicity with SGE has spurred efforts to expand this and related techniques to many more genes.

摘要

在基因组医学时代,准确解读人类遗传数据对于优化治疗效果至关重要。用于测试基因变异功能效应的强大方法使研究人员能够对数千种跨疾病基因的变异进行表征。在这里,我们回顾了能够实现变异体高度可扩展检测的实验工具,特别关注饱和基因组编辑(SGE)。我们讨论了该技术如何大规模用于变异体检测的实例,并描述了SGE数据如何经过临床验证并用于辅助变异体解读。利用SGE预测变异体致病性的初步成功激发了将该技术及相关技术扩展到更多基因的努力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c96e/11006300/b091a2d019dc/j_medgen-2022-2159_fig_003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c96e/11006300/1c76c6f7bba7/j_medgen-2022-2159_fig_001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c96e/11006300/1f2bc5eec0d2/j_medgen-2022-2159_fig_002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c96e/11006300/b091a2d019dc/j_medgen-2022-2159_fig_003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c96e/11006300/1c76c6f7bba7/j_medgen-2022-2159_fig_001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c96e/11006300/1f2bc5eec0d2/j_medgen-2022-2159_fig_002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c96e/11006300/b091a2d019dc/j_medgen-2022-2159_fig_003.jpg

相似文献

1
Reducing uncertainty in genetic testing with Saturation Genome Editing.利用饱和基因组编辑降低基因检测中的不确定性。
Med Genet. 2022 Nov 29;34(4):297-304. doi: 10.1515/medgen-2022-2159. eCollection 2022 Dec.
2
Clinical phenotypes combined with saturation genome editing identifying the pathogenicity of BRCA1 variants of uncertain significance in breast cancer.临床表型与饱和基因组编辑相结合鉴定乳腺癌中意义未明的BRCA1变异的致病性
Fam Cancer. 2021 Apr;20(2):85-95. doi: 10.1007/s10689-020-00202-4. Epub 2020 Aug 17.
3
Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.利用 CRISPR/Cas9 和人诱导多能干细胞确定不确定意义的基因组变异的致病性。
Circulation. 2018 Dec 4;138(23):2666-2681. doi: 10.1161/CIRCULATIONAHA.117.032273.
4
Saturation genome editing-based functional evaluation and clinical classification of BRCA2 single nucleotide variants.基于饱和基因组编辑的BRCA2单核苷酸变异的功能评估与临床分类
bioRxiv. 2023 Dec 15:2023.12.14.571597. doi: 10.1101/2023.12.14.571597.
5
Variant Library Annotation Tool (VaLiAnT): an oligonucleotide library design and annotation tool for saturation genome editing and other deep mutational scanning experiments.变体文库注释工具(VaLiAnT):用于饱和基因组编辑和其他深度突变扫描实验的寡核苷酸文库设计和注释工具。
Bioinformatics. 2022 Jan 27;38(4):892-899. doi: 10.1093/bioinformatics/btab776.
6
Functional pre-therapeutic evaluation by genome editing of variants of uncertain significance of essential tumor suppressor genes.通过基因组编辑对重要肿瘤抑制基因的意义未明变异体进行功能预治疗评估。
Genome Med. 2021 Nov 9;13(1):174. doi: 10.1186/s13073-021-00976-x.
7
Assessing concordance among human, in silico predictions and functional assays on genetic variant classification.评估遗传变异分类中人类、计算机预测和功能测定之间的一致性。
Bioinformatics. 2019 Dec 15;35(24):5163-5170. doi: 10.1093/bioinformatics/btz442.
8
Saturation mutagenesis-reinforced functional assays for disease-related genes.基于饱和突变增强的疾病相关基因功能分析
Cell. 2024 Nov 14;187(23):6707-6724.e22. doi: 10.1016/j.cell.2024.08.047. Epub 2024 Sep 25.
9
Deep Mutational Scanning in Disease-related Genes with Saturation Mutagenesis-Reinforced Functional Assays (SMuRF).利用饱和诱变强化功能分析(SMuRF)对疾病相关基因进行深度突变扫描
bioRxiv. 2024 Jun 25:2023.07.12.548370. doi: 10.1101/2023.07.12.548370.
10
Towards a New, Endophenotype-Based Strategy for Pathogenicity Prediction in BRCA1 and BRCA2: In Silico Modeling of the Outcome of HDR/SGE Assays for Missense Variants.BRCA1 和 BRCA2 致病性预测的新型基于内表型策略:错义变体 HDR/SGE 测定结果的计算机建模。
Int J Mol Sci. 2021 Jun 9;22(12):6226. doi: 10.3390/ijms22126226.

引用本文的文献

1
Synthetic lethality in cancer drug discovery: challenges and opportunities.癌症药物研发中的合成致死性:挑战与机遇
Nat Rev Drug Discov. 2025 Sep 11. doi: 10.1038/s41573-025-01273-7.

本文引用的文献

1
Saturation genome editing of DDX3X clarifies pathogenicity of germline and somatic variation.全基因组编辑 DDX3X 阐明了胚系和体细胞变异的致病性。
Nat Commun. 2023 Dec 6;14(1):7702. doi: 10.1038/s41467-023-43041-4.
2
The sequences of 150,119 genomes in the UK Biobank.英国生物库中 150119 个基因组的序列。
Nature. 2022 Jul;607(7920):732-740. doi: 10.1038/s41586-022-04965-x. Epub 2022 Jul 20.
3
Saturation variant interpretation using CRISPR prime editing.使用 CRISPR 先导编辑进行饱和变异解读。
Nat Biotechnol. 2022 Jun;40(6):885-895. doi: 10.1038/s41587-021-01201-1. Epub 2022 Feb 21.
4
Clinical validation of genomic functional screen data: Analysis of observed variants in an unselected population cohort.基因组功能筛选数据的临床验证:未选择人群队列中观察到的变异分析。
HGG Adv. 2022 Jan 8;3(2):100086. doi: 10.1016/j.xhgg.2022.100086. eCollection 2022 Apr 14.
5
Publisher Correction: Disease variant prediction with deep generative models of evolutionary data.出版商更正:使用进化数据的深度生成模型进行疾病变异预测。
Nature. 2022 Jan;601(7892):E7. doi: 10.1038/s41586-021-04207-6.
6
Improved pathogenicity prediction for rare human missense variants.改善对罕见人类错义变体的致病性预测。
Am J Hum Genet. 2021 Dec 2;108(12):2389. doi: 10.1016/j.ajhg.2021.11.010.
7
Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease.贝伐珠单抗治疗 von Hippel-Lindau 病相关肾细胞癌
N Engl J Med. 2021 Nov 25;385(22):2036-2046. doi: 10.1056/NEJMoa2103425.
8
Closing the gap: Systematic integration of multiplexed functional data resolves variants of uncertain significance in BRCA1, TP53, and PTEN.缩小差距:多重功能数据的系统整合解决了 BRCA1、TP53 和 PTEN 中不确定意义的变体。
Am J Hum Genet. 2021 Dec 2;108(12):2248-2258. doi: 10.1016/j.ajhg.2021.11.001. Epub 2021 Nov 17.
9
From variant to function in human disease genetics.从变异到人类疾病遗传学中的功能。
Science. 2021 Sep 24;373(6562):1464-1468. doi: 10.1126/science.abi8207. Epub 2021 Sep 23.
10
Linking genome variants to disease: scalable approaches to test the functional impact of human mutations.将基因组变异与疾病联系起来:可扩展的方法来测试人类突变的功能影响。
Hum Mol Genet. 2021 Oct 1;30(R2):R187-R197. doi: 10.1093/hmg/ddab219.